With advanced pellets coating technologies, Allist developed Lansoprazole and Pantoprazole Enteric-coated (Pellets) Capsules. The two drugs are proton pump inhibitors for indications of gastric acid related diseases. The two drugs will be produced by joint efforts of Allist and Shanghai Ethypharm. ( www.ethypharm.com.cn ) The two companies have reached an agreement for co-developing the two new drug. Shanghai Ethypharm is a pharmaceutical company specialized in new formulation development and producing. It is a subsidiary company of French Ethypharm Group, the leader in drug releasing technology. The two products were filed for producing license in July, 2006 and were expected to come into market in early 2007.

Compared with conventional enteric-coated tablets, Allist's enteric-coated pellets has advantages of accelerating gastric passage, lowering regional stimulus of gastrointestinal mucosa, increasing bioavailability and avoiding dosage running off caused by enteric coating fault. All these advantages result in increased cure effects and better application in clinical settings.